HK Stock MarketDetailed Quotes

01952 EVEREST MED-B

Watchlist
  • 35.150
  • +0.350+1.01%
Market Closed Nov 15 16:08 CST
11.46BMarket Cap-9926P/E (TTM)

EVEREST MED-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q3)Mar 31, 2020
(FY)Dec 31, 2019
Turnover
3,289.74%301.52M
884.46%125.93M
752.01%8.9M
23,588.89%12.79M
--1.04M
--54K
----
----
----
----
Operating income
3,289.74%301.52M
884.46%125.93M
752.01%8.9M
23,588.89%12.79M
1.04M
54K
Cost of sales
-2,022.91%-70.44M
-640.88%-34.41M
-811.54%-3.32M
-20,095.65%-4.65M
---364K
---23K
----
----
----
----
Operating expenses
-2,022.91%-70.44M
-640.88%-34.41M
-811.54%-3.32M
-20,095.65%-4.65M
-364K
-23K
Gross profit
4,043.43%231.08M
1,023.33%91.52M
720.15%5.58M
26,180.65%8.15M
680K
31K
Selling expenses
-212.48%-200.39M
29.16%-231.42M
56.72%-64.13M
-64.87%-326.69M
-251.94%-148.16M
-496.01%-198.15M
---42.1M
---33.25M
---2.8M
----
Administrative expenses
-4.65%-87M
40.28%-165.16M
30.09%-83.13M
-13.96%-276.55M
-10.69%-118.91M
12.65%-242.68M
---107.43M
-415.93%-277.83M
-740.09%-68.15M
25.31%-53.85M
Research and development expenses
12.25%-253.16M
33.30%-540.05M
16.50%-288.49M
-32.00%-809.74M
-37.78%-345.51M
-62.54%-613.43M
---250.77M
-150.13%-377.41M
-251.56%-80.18M
-169.87%-150.89M
Special items of operating profit
-643.10%-362.29M
-107.63%-87.63M
-75.70%-48.75M
4,015.37%1.15B
-365.43%-27.75M
84,433.33%27.9M
---5.96M
-99.88%33K
-75.40%153K
3,369.94%28.63M
Operating profit
-40.26%-671.76M
-263.22%-932.74M
25.13%-478.93M
74.98%-256.8M
-57.45%-639.65M
-49.08%-1.03B
-406.26M
-290.92%-688.46M
-398.31%-150.98M
-38.47%-176.11M
Financing income
-37.49%34.23M
157.27%84.61M
1,075.59%54.76M
36.66%32.89M
---5.61M
175.86%24.07M
----
---31.73M
----
----
Financing cost
----
----
----
----
----
----
--26.52M
----
-42.18%-573K
-46.94%-1.95M
Special items of earning before tax
823.47%5.12M
115.70%3.67M
102.43%554K
-262.09%-23.36M
-576.94%-22.78M
99.87%-6.45M
---3.37M
-13,446.16%-4.94B
250.87%455.51M
95.78%-36.45M
Earning before tax
-49.29%-632.41M
-241.51%-844.46M
36.59%-423.61M
75.49%-247.28M
-74.37%-668.04M
82.17%-1.01B
-383.11M
-2,537.69%-5.66B
206.65%303.96M
78.37%-214.51M
Tax
----
----
----
---8K
----
----
----
----
----
----
After-tax profit from continuing operations
-49.29%-632.41M
-241.50%-844.46M
36.59%-423.61M
75.49%-247.28M
-74.37%-668.04M
82.17%-1.01B
-383.11M
-2,537.69%-5.66B
206.65%303.96M
78.37%-214.51M
Earning after tax
-49.29%-632.41M
-241.50%-844.46M
36.59%-423.61M
75.49%-247.28M
-74.37%-668.04M
82.17%-1.01B
-383.11M
-2,537.69%-5.66B
206.65%303.96M
78.37%-214.51M
Profit attributable to shareholders
-49.29%-632.41M
-241.50%-844.46M
36.59%-423.61M
75.49%-247.28M
-74.37%-668.04M
82.17%-1.01B
-383.11M
-2,537.69%-5.66B
206.65%303.96M
78.37%-214.51M
Basic earnings per share
-40.71%-1.97
-225.30%-2.7
38.05%-1.4
75.87%-0.83
-72.52%-2.26
94.81%-3.44
-1.31
-61.53%-66.29
-69.15%12.29
94.35%-41.04
Diluted earnings per share
-40.71%-1.97
-225.30%-2.7
38.05%-1.4
75.87%-0.83
-72.52%-2.26
94.81%-3.44
-1.31
-61.53%-66.29
-223.81%-0.68
94.35%-41.04
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q3)Mar 31, 2020(FY)Dec 31, 2019
Turnover 3,289.74%301.52M884.46%125.93M752.01%8.9M23,588.89%12.79M--1.04M--54K----------------
Operating income 3,289.74%301.52M884.46%125.93M752.01%8.9M23,588.89%12.79M1.04M54K
Cost of sales -2,022.91%-70.44M-640.88%-34.41M-811.54%-3.32M-20,095.65%-4.65M---364K---23K----------------
Operating expenses -2,022.91%-70.44M-640.88%-34.41M-811.54%-3.32M-20,095.65%-4.65M-364K-23K
Gross profit 4,043.43%231.08M1,023.33%91.52M720.15%5.58M26,180.65%8.15M680K31K
Selling expenses -212.48%-200.39M29.16%-231.42M56.72%-64.13M-64.87%-326.69M-251.94%-148.16M-496.01%-198.15M---42.1M---33.25M---2.8M----
Administrative expenses -4.65%-87M40.28%-165.16M30.09%-83.13M-13.96%-276.55M-10.69%-118.91M12.65%-242.68M---107.43M-415.93%-277.83M-740.09%-68.15M25.31%-53.85M
Research and development expenses 12.25%-253.16M33.30%-540.05M16.50%-288.49M-32.00%-809.74M-37.78%-345.51M-62.54%-613.43M---250.77M-150.13%-377.41M-251.56%-80.18M-169.87%-150.89M
Special items of operating profit -643.10%-362.29M-107.63%-87.63M-75.70%-48.75M4,015.37%1.15B-365.43%-27.75M84,433.33%27.9M---5.96M-99.88%33K-75.40%153K3,369.94%28.63M
Operating profit -40.26%-671.76M-263.22%-932.74M25.13%-478.93M74.98%-256.8M-57.45%-639.65M-49.08%-1.03B-406.26M-290.92%-688.46M-398.31%-150.98M-38.47%-176.11M
Financing income -37.49%34.23M157.27%84.61M1,075.59%54.76M36.66%32.89M---5.61M175.86%24.07M-------31.73M--------
Financing cost --------------------------26.52M-----42.18%-573K-46.94%-1.95M
Special items of earning before tax 823.47%5.12M115.70%3.67M102.43%554K-262.09%-23.36M-576.94%-22.78M99.87%-6.45M---3.37M-13,446.16%-4.94B250.87%455.51M95.78%-36.45M
Earning before tax -49.29%-632.41M-241.51%-844.46M36.59%-423.61M75.49%-247.28M-74.37%-668.04M82.17%-1.01B-383.11M-2,537.69%-5.66B206.65%303.96M78.37%-214.51M
Tax ---------------8K------------------------
After-tax profit from continuing operations -49.29%-632.41M-241.50%-844.46M36.59%-423.61M75.49%-247.28M-74.37%-668.04M82.17%-1.01B-383.11M-2,537.69%-5.66B206.65%303.96M78.37%-214.51M
Earning after tax -49.29%-632.41M-241.50%-844.46M36.59%-423.61M75.49%-247.28M-74.37%-668.04M82.17%-1.01B-383.11M-2,537.69%-5.66B206.65%303.96M78.37%-214.51M
Profit attributable to shareholders -49.29%-632.41M-241.50%-844.46M36.59%-423.61M75.49%-247.28M-74.37%-668.04M82.17%-1.01B-383.11M-2,537.69%-5.66B206.65%303.96M78.37%-214.51M
Basic earnings per share -40.71%-1.97-225.30%-2.738.05%-1.475.87%-0.83-72.52%-2.2694.81%-3.44-1.31-61.53%-66.29-69.15%12.2994.35%-41.04
Diluted earnings per share -40.71%-1.97-225.30%-2.738.05%-1.475.87%-0.83-72.52%-2.2694.81%-3.44-1.31-61.53%-66.29-223.81%-0.6894.35%-41.04
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data